These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35184152)

  • 1. Towards diagnostic criteria for malignant deep penetrating melanocytic tumors using single nucleotide polymorphism array and next-generation sequencing.
    Ebbelaar CF; Schrader AMR; van Dijk M; Meijers RWJ; de Leng WWJ; Bloem LT; Jansen AML; Blokx WAM;
    Mod Pathol; 2022 Aug; 35(8):1110-1120. PubMed ID: 35184152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Catenin nuclear expression discriminates deep penetrating nevi from other cutaneous melanocytic tumors.
    de la Fouchardière A; Caillot C; Jacquemus J; Durieux E; Houlier A; Haddad V; Pissaloux D
    Virchows Arch; 2019 May; 474(5):539-550. PubMed ID: 30756182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of atypical deep penetrating nevus progressing to melanoma.
    Isales MC; Khan AU; Zhang B; Compres EV; Kim D; Tan TL; Beaubier N; Gerami P
    J Cutan Pathol; 2020 Dec; 47(12):1150-1154. PubMed ID: 32526042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined WNT-activated deep-penetrating/plexiform melanocytoma: insights into clinicopathological and molecular characterization.
    Castillo P; Castrejon N; Marginet M; Massi D; Alamon F; Teixido C; Montironi C; Garcia-Herrera A; Albero-Gonzalez R; Matas J; Puig S; Alos L
    Clin Exp Dermatol; 2024 Mar; 49(4):356-363. PubMed ID: 37995304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
    Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
    Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superficial Wnt-Activated Melanocytic Nevi/Melanocytomas With a Junctional Component: A Case Series.
    Ng S; Hall KC; Busam KJ; Lezcano C; Moy AP; Pulitzer M; Sriharan A; Yan S; Linos K
    Am J Dermatopathol; 2024 Oct; 46(10):648-652. PubMed ID: 39141718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRAME and LEF1 in Combined Deep Penetrating Nevus and Combined Blue Nevus: Utility and Pitfalls.
    Vanderbeck K; Rothrock AT; Cho WC; Nagarajan P; Aung PP; Hudgens C; Bassett RL; Ivan D; Prieto VG; Curry JL; Torres-Cabala CA
    Am J Dermatopathol; 2023 Aug; 45(8):549-556. PubMed ID: 37462205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Atypical Deep Penetrating Nevus With Mutations in Beta Catenin , BRAFV600E , and IDH1R132C in an 8-Year-Old Boy.
    Ireland AM; Wood BA; Whitfield J; Amanuel B; Harvey NT; Mesbah Ardakani N
    Am J Dermatopathol; 2022 Aug; 44(8):607-610. PubMed ID: 35385855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRAME Immunohistochemical Expression and TERT Promoter Mutational Analysis as Ancillary Diagnostic Tools for Differentiating Proliferative Nodules From Melanoma Arising in Congenital Nevi.
    Boutko A; Hagstrom M; Lampley N; Roth A; Olivares S; Dhillon S; Fumero-Velázquez M; Benton S; Zhao J; Zhang B; Dittmann D; Asadbeigi S; Busam KJ; Gerami P
    Am J Dermatopathol; 2023 Jul; 45(7):437-447. PubMed ID: 37338065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanocytic Skin Neoplasms: What Lesson From Genomic Aberrations?
    Urso C
    Am J Dermatopathol; 2019 Sep; 41(9):623-629. PubMed ID: 31433323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Busam KJ
    Am J Surg Pathol; 2020 Jul; 44(7):893-900. PubMed ID: 32317605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Utility of LEF1 Immunohistochemistry in Differentiating Deep Penetrating Nevi From Histologic Mimics.
    Raghavan SS; Saleem A; Wang JY; Rieger KE; Brown RA; Novoa RA
    Am J Surg Pathol; 2020 Oct; 44(10):1413-1418. PubMed ID: 32520758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocytic naevi, melanocytomas and emerging concepts.
    Yeh I
    Pathology; 2023 Mar; 55(2):178-186. PubMed ID: 36642570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation sequencing revealing TP53 mutation as potential genetic driver in dermal deep-seated melanoma arising in giant congenital nevus in adult patients: A unique case report and review of the literature.
    Ricci C; Ambrosi F; Grillini M; Serra M; Melotti B; Gruppioni E; Altimari A; Fiorentino M; Dika E; Lambertini M; Corti B
    J Cutan Pathol; 2020 Dec; 47(12):1164-1169. PubMed ID: 32643812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanocytic lesions, Spitz tumors, and Don Ferrante's logic.
    Urso C
    Am J Dermatopathol; 2007 Oct; 29(5):491-4. PubMed ID: 17890925
    [No Abstract]   [Full Text] [Related]  

  • 16. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
    Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
    Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRAME Expression in Challenging Dermal Melanocytic Neoplasms and Soft Tissue Tumors With Melanocytic Differentiation.
    Kline N; Menge TD; Hrycaj SM; Andea AA; Patel RM; Harms PW; Chan MP; Bresler SC
    Am J Dermatopathol; 2022 Jun; 44(6):404-410. PubMed ID: 34991102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma.
    Colebatch AJ; Paver EC; Vergara IA; Thompson JF; Long GV; Wilmott JS; Scolyer RA
    Pathology; 2022 Aug; 54(5):533-540. PubMed ID: 35248370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms.
    Lee JJ; Vilain RE; Granter SR; Hu NR; Bresler SC; Xu S; Frank AH; Mihm MC; Saw RP; Fletcher CD; Scolyer RA; Murphy GF; Lian CG
    J Cutan Pathol; 2017 Mar; 44(3):249-255. PubMed ID: 28032662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic utility of PRAME and p16 in distinguishing nodal nevi from nodal metastatic melanoma.
    See SHC; Finkelman BS; Yeldandi AV
    Pathol Res Pract; 2020 Sep; 216(9):153105. PubMed ID: 32825968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.